Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 9, 2015, Pages 1127-1134

  Olin, Per ^a   Hausken, John ^a   Foss, Aksel ^a,b   Karlsen, Tom Hemming ^a,b   Melum, Espen ^a   Haugaa, Håkon ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Encephalopathy; Intensive care medicine

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AMMONIA; BILIRUBIN; CALCIUM; CREATININE; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; MAGNESIUM; PHOSPHATE; POTASSIUM; SODIUM;

ACUTE LIVER FAILURE; ACUTE ON CHRONIC LIVER FAILURE; ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALBUMIN DIALYSIS; ALCOHOL LIVER CIRRHOSIS; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; APACHE; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; BLOOD FILTER; BRAIN HEMORRHAGE; CALCIUM BLOOD LEVEL; CAUSE OF DEATH; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; ESOPHAGUS VARICES; FEMALE; FIBRINOGEN BLOOD LEVEL; FLOW RATE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART INFARCTION; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; HUMAN; INFANT; INTERNATIONAL NORMALIZED RATIO; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER TRANSPLANTATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PEROPERATIVE COMPLICATION; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SHOCK; SODIUM BLOOD LEVEL; SURVIVAL TIME; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY EFFECT; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UREA BLOOD LEVEL; ACUTE-ON-CHRONIC LIVER FAILURE; END STAGE LIVER DISEASE; HEMODIALYSIS; INTENSIVE CARE UNIT; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; STATISTICAL MODEL; TERTIARY CARE CENTER; YOUNG ADULT;

ACUTE-ON-CHRONIC LIVER FAILURE; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; END STAGE LIVER DISEASE; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84934298767     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1027262     Document Type: Article

References (35)

1. Bernal W, Wendon J. Acute liver failure. N Engl JMed 2013; 369:2525-34.
2. Kim TY, Kim DJ. Acute-on-chronic liver failure. Clin Mol Hepatol 2013;19:349-59.
3. Liou IW. Management of end-stage liver disease. Med Clin North Am 2014;98:119-52.
4. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5.
5. Krisper P, Stadlbauer V, Stauber RE. Clearing of toxic substances: Are there differences between the available liver support devices? Liver Int 2011;31:5-8.
6. Faybik P, Krenn CG. Extracorporeal liver support. Curr Opin Crit Care 2013;19:149-53.
7. Banares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-onchronic liver failure: The RELIEF trial. Hepatology 2013;57: 1153-62.
8. Pares A, Deulofeu R, Cisneros L, Escorsell A, Salmeron JM, Caballeria J, et al. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit Care 2009;13:R8.
9. Chiu A, Tsoi NS, Fan ST. Use of the molecular adsorbents recirculating system as a treatment for acute decompensated Wilson disease. Liver Transpl 2008;14:1512-16.
10. Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007;46:1853-62.
11. Vaid A, Chweich H, Balk EM, Jaber BL. Molecular adsorbent recirculating system as artificial support therapy for liver failure: A meta-analysis. ASAIO J 2012;58:51-9.
12. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology 2002;36:949-58.
13. Galbois A, Das V, Carbonell N, Guidet B. Prognostic scores for cirrhotic patients admitted to an intensive care unit: which consequences for liver transplantation? Clin Res Hepatol Gastroenterol 2013;37:455-66.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29.
15. Vincent JL, Moreno R, Takala J, Willatts S, De MA, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensive Care Med 1996;22:707-10.
16. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
17. Scandiatransplant. Available from http://www.scandiatransplant. org. 2014.
18. Lee WM. Acute liver failure. Semin Respir Crit Care Med 2012;33:36-45.
19. Ott P, Vilstrup H. Cerebral effects of ammonia in liver disease: current hypotheses. Metab Brain Dis 2014;29:901-11.
20. Slack AJ, Auzinger G, Willars C, Dew T, Musto R, Corsilli D, et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int 2014;34:42-8.
21. Agarwal B, Wright G, Gatt A, Riddell A, Vemala V, Mallett S, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol 2012;57:780-6.
22. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Mullhaupt B, Renner EL. Artificial liver support with the molecular adsorbent recirculating system: Activation of coagulation and bleeding complications. Liver Int 2007;27:475-84.
23. Doria C, Mandala L, Smith JD, Caruana G, Scott VL, Gruttadauria S, et al. Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004;18:365-71.
24. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993;341:157-8.
25. Larsen FS, Wendon J. Prevention and management of brain edema in patients with acute liver failure. Liver Transpl 2008; 14:S90-6.
26. Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging 2010;34:327-31.
27. Mohsenin V. Assessment and management of cerebral edema and intracranial hypertension in acute liver failure. J Crit Care 2013;28:783-91.
28. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Kim I, et al. The relationship between hypophosphataemia and outcomes during low-intensity and high-intensity continuous renal replacement therapy. Crit Care Resusc 2014;16:34-41.
29. Cordoba J, Garcia-Martinez R, Simon-Talero M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis 2010;25:73-80.
30. Santoro A, Faenza S, Mancini E, Ferramosca E, Grammatico F, Zucchelli A, et al. Prometheus system: A technological support in liver failure. Transplant Proc 2006;38:1078-82.
31. Ringe H, Varnholt V, Zimmering M, Luck W, Gratopp A, Konig K, et al. Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med 2011;12:257-64.
32. Ye JL, Ye B, Lv JX, Mao WL, Gu B. Changes of ammonia levels in patients with acute on chronic liver failure treated by plasma exchange. Hepatogastroenterology 2014;61:141-5.
33. Stenbog P, Busk T, Larsen FS. Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchange. Metab Brain Dis 2013;28:333-5.
34. Fisher JE, Lillegard JB, McKenzie TJ, Rodysill BR, Wettstein PJ, Nyberg SL. In utero transplanted human hepatocytes allow postnatal engraftment of human hepatocytes in pigs. Liver Transpl 2013;19:328-35.
35. Nyberg SL. Bridging the gap: Advances in artificial liver support. Liver Transpl 2012;18:S10-14.